In the News

The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions. This section includes news on pharmaceutical companies, mergers and acquisitions, drug development, export and import of drugs, legislation, advertising and influence.

Simple drug formula regenerates brain cells
Scientists have shown how a drug cocktail of four compounds can convert glia, or support cells, next to damaged neurons into new working neurons.

Colorectal cancer: Scientists halt growth with cannabinoid compounds
Scientists have identified a number of synthetic cannabinoid compounds that can halt the growth of several types of human colorectal cancer cells.

Antibiotics disrupt gut bacteria, impact bone health
According to one intriguing new study, antibiotics may disrupt bone health by interacting with gut bacteria and the immune system.

Multiple sclerosis: Small molecule could delay onset
Neuroprotective treatment with the small molecule Sephin1, significantly delayed loss of myelin and damage to cells in a mouse model of MS.

Breast cancer: Changing tumor cells into fat cells stops spread
By exploiting cancer cells' innate adaptability, scientists halt invasive spread in mice by transforming malignant breast cancer cells into fat cells.

Triple-negative breast cancer responds to new dual-target therapy
An experimental therapy that targets two growth pathways reduced cancer cell proliferation and spread in mice with triple-negative breast cancer.

Antibiotic resistance: Old Irish 'soil cure' tackles major superbugs
Newly identified bacteria in Irish soil long used in folk medicine stops growth of MRSA and three other superbugs behind antibiotic-resistant infections.

Diabetes: Drug duo helps body replenish its insulin-producing cells
A new drug combination that spurs adult human beta cells on to regenerate at an unprecedented 5–8 percent per day is a big step toward a diabetes cure.

Multiple sclerosis: Could this be why myelin fails to regenerate?
A study finds a previously unknown mechanism that quietens adult stem cells and could be a disruptor of myelin repair in inflammatory diseases, such as MS.

How to make kefir more healthful using sound
Kefir is credited with a range of health benefits. Recently, researchers tried to boost levels of one of its active ingredients using ultrasound.

Spray gel could reduce cancer spread after surgery
A 'sprayable gel' embedded with nanoparticles carrying drugs that boost immunity controlled tumor recurrence at surgery site and at distant sites in mice.

'Simple modification' could help antibiotics overcome resistance
A simple way of linking vancomycin to an antimicrobial peptide led to a fivefold increase in the antibiotic's power against an infectious bacterium.

Antibiotic resistance: Breakthrough study offers solution
Mice treated with small molecules that stop bacteria forming toxins survived MRSA infection without the need for antibiotics, study found.

How a 150-year old drug might help battle cancer
The potency of cancer treatments is often reduced by a lack of oxygen in and around the tumor. Researchers have found an existing drug that might help.

High blood pressure control with 'exercise in a pill'
Increased body levels of a compound that the liver makes could control high blood pressure without having to exercise or eat less salt, study suggests.

What is the difference between clonazepam and Xanax?
Clonazepam and Xanax both belong to a class of drugs called benzodiazepines. As a result, they are quite similar, but doctors may prescribe them for different reasons. Learn more about the differences in their uses, effects, and dosages here.

Read More

News Releases

Keep up on the latest news from VMS BioMarketing. Links to featured news releases are posted below.

New Business Development VP Karen Josey Will Build Awareness of Clinical Educators to Improve Patient Compliance as VMS BioMarketing Moves Into Phase II-IV Clinical Trial Space
Posted on Wednesday January 16, 2019

Helping Patients Set Healthy Goals for the New Year
Posted on Wednesday January 02, 2019

VMS BioMarketing Clinical Educator Teresita Buenrostro shares how to help patients improve self-management of chronic illnesses

VMS BioMarketing Launches New Corporate Website
Posted on Tuesday June 05, 2018

New website provides practical solutions to challenges of medication adherence

VMS to Sponsor Oncology Nursing Society 'Mara' Lecture Addressing Topics Related to the Psychosocial Aspects of Cancer
Posted on Tuesday May 15, 2018

VMS BioMarketing Clinical Educators Gear Up to Help Reduce HIV Risks
Posted on Wednesday May 02, 2018

Healthcare provider education aimed at preventing opioid-related HIV outbreaks

Awards + Recognition

VMS has experienced more than two decades of success by strategically partnering with our clients to continually provide best-in-class service. We have been recognized for our key contributions and impressive growth.

For the third consecutive year, rated a Great Place to Work® by the experts who produce FORTUNE's 100 Best Companies to Work For® list

Named one of the 2017 Best Workplaces for Giving Back by Fortune magazine and a Great Place to Work
Selected by Fortune magazine as one of the "100 Best Medium Workplaces" in America, with rankings based on anonymous surveys from more than 52,000 employees at Great Place to Work®-certified companies
Great Place to Work® and Fortune magazine recognized VMS BioMarketing as one of the 100 Best Workplaces for Women
Selected as a "Most Valuable Patient Initiative" Finalist and a "Most Valuable HCP Initiative" Finalist at the 2017 Eyeforpharma Awards
Named three times as one of Inc. 500's "Fastest Growing Companies in America"
Recognized by a Fortune 500 pharmaceutical client with a "Global Supplier of the Year" award
Recognized by the Edward Lowe Foundation as one of the "Indiana Companies to Watch" in 2008
Recognized by Working Mother magazine in 2008 as a Top 25 outstanding family-friendly company
Received "Family Friendly Workplace" award from the Indiana Youth Institute in 2008
Highlighted as a "Growth 100" company by the Kelley School of Business Johnson Center for Entrepreneurship and Innovation
Selected as one of Ernst and Young's "Entrepreneur of the Year" finalists
Listed in the top five of the Best Places to Work in Indiana three years in a row